Singapore Cell And Gene Therapy Thawing Equipment Market to 2032
Overview
The Singapore Cell And Gene Therapy Thawing Equipment Market is expected to reach a 46.49 USD Million by 2032 and is projected to grow at a CAGR of 23.11% from 2025 to 2032.
Revenue, 2024 (USD Million)
15.25
Forecast, 2032 (USD Million)
46.49
CAGR, 2024 - 2032
23.11%
Report Coverage
Singapore
Singapore Cell And Gene Therapy Thawing Equipment Market 2018-2032 USD Million
Singapore Cell And Gene Therapy Thawing Equipment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 15.25 USD Million
- Projected Market Size (2032): 46.49 USD Million
- CAGR (2025-2032): 23.11%
Key Findings of Singapore Cell And Gene Therapy Thawing Equipment Market
- The Singapore Cell And Gene Therapy Thawing Equipment Market was valued at 15.25 USD Million in 2024.
- The Singapore Cell And Gene Therapy Thawing Equipment Market is likely to grow at a CAGR of 23.11% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cell Therapies in Sample Segment accounted for the largest share of the market with a revenue of 12.51 USD Million
- The fastest growing segment Blood Banks And Transfusion Centers in End User Segment grew Fastest with a CAGR of 25.24% during the forecast period from 2024 to 2032.
Singapore Cell And Gene Therapy Thawing Equipment Market Scope
Singapore Cell And Gene Therapy Thawing Equipment Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distributors
- Direct Tender
End User
- Others
- Gene Banks
- Cord Blood And Stem Cell Banks
- Biotechnology And Pharmaceutical Industry
- Research Laboratories And Academic Institutes
- Blood Banks And Transfusion Centers
- Hospitals And Diagnostic Laboratories
Application
- Downstream Processing
- Upstream Processing
Type
- Manual Thawing System
- Automatic Thawing System
Sample
- Gene Therapies
- Cell Therapies
Modality
- Portable
- Bench Top
Singapore Cell And Gene Therapy Thawing Equipment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 15.25 USD Million |
| Market Value in 2032 | 46.49 USD Million |
| CAGR (2025-2032) | 23.11% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, End User, Application, Type, Sample, Modality |
Regional Insights:
-
Leading Market (2024-2032): Singapore, leading in terms of revenue 15.25 USD Million in 2024
- Key Country: Singapore, leading in terms of revenue with value of 15.25 USD Million in 2024.
Segments and Scope
-
Singapore Cell And Gene Therapy Thawing Equipment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 10.76 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 24.49 % in forecast period 2025-2032.
-
Singapore Cell And Gene Therapy Thawing Equipment Market to 2032, By End User
- Hospitals And Diagnostic Laboratories is the largest segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 5.33 USD Million in the year 2024.
- Blood Banks And Transfusion Centers is the Fastest growing segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 23.11 % in forecast period 2025-2032.
-
Singapore Cell And Gene Therapy Thawing Equipment Market to 2032, By Application
- Upstream Processing is the largest segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 11.52 USD Million in the year 2024.
- Upstream Processing is the Fastest growing segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 23.70 % in forecast period 2025-2032.
-
Singapore Cell And Gene Therapy Thawing Equipment Market to 2032, By Type
- Automatic Thawing System is the largest segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 12.23 USD Million in the year 2024.
- Automatic Thawing System is the Fastest growing segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 23.48 % in forecast period 2025-2032.
-
Singapore Cell And Gene Therapy Thawing Equipment Market to 2032, By Sample
- Cell Therapies is the largest segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 12.51 USD Million in the year 2024.
- Gene Therapies is the Fastest growing segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 22.78 % in forecast period 2025-2032.
-
Singapore Cell And Gene Therapy Thawing Equipment Market to 2032, By Modality
- Bench Top is the largest segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 12.25 USD Million in the year 2024.
- Portable is the Fastest growing segment in Singapore Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 22.87 % in forecast period 2025-2032.
Singapore Cell And Gene Therapy Thawing Equipment Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Sartorius AG | |||
| Cytiva | |||
| Eppendorf | |||
Singapore Cell And Gene Therapy Thawing Equipment Market Geographical Sales Distribution, 2018-2032 USD Million
Singapore Cell And Gene Therapy Thawing Equipment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Singapore Cell And Gene Therapy Thawing Equipment Market is segmented based on Segmentation Distribution Channel, End User, Application, Type, Sample, Modality.
Singapore Cell And Gene Therapy Thawing Equipment Market was valued at USD 15.25(Revenue in USD Million) in 2020.
Singapore Cell And Gene Therapy Thawing Equipment Market is projected to grow at a CAGR of 23.11% during the forecast period of 2024 to 2032.
The Cell Therapies segment is expected to dominate the Singapore Cell And Gene Therapy Thawing Equipment Market, holding a largest market share of 12.51 USD Million in 2024
Singapore Cell And Gene Therapy Thawing Equipment Market Scope
Singapore Cell And Gene Therapy Thawing Equipment Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distributors
- Direct Tender
End User
- Others
- Gene Banks
- Cord Blood And Stem Cell Banks
- Biotechnology And Pharmaceutical Industry
- Research Laboratories And Academic Institutes
- Blood Banks And Transfusion Centers
- Hospitals And Diagnostic Laboratories
Application
- Downstream Processing
- Upstream Processing
Type
- Manual Thawing System
- Automatic Thawing System
Sample
- Gene Therapies
- Cell Therapies
Modality
- Portable
- Bench Top
Frequently Asked Questions
The Singapore Cell And Gene Therapy Thawing Equipment Market is segmented based on Segmentation Distribution Channel, End User, Application, Type, Sample, Modality.
Singapore Cell And Gene Therapy Thawing Equipment Market was valued at USD 15.25(Revenue in USD Million) in 2020.
Singapore Cell And Gene Therapy Thawing Equipment Market is projected to grow at a CAGR of 23.11% during the forecast period of 2024 to 2032.
The estimated market value of the Singapore Cell And Gene Therapy Thawing Equipment Market for final year is USD 46.49 (USD Million).
Singapore Cell And Gene Therapy Thawing Equipment Market Company Profiling
Frequently Asked Questions
The Singapore Cell And Gene Therapy Thawing Equipment Market is segmented based on Segmentation Distribution Channel, End User, Application, Type, Sample, Modality.
Singapore Cell And Gene Therapy Thawing Equipment Market was valued at USD 15.25(Revenue in USD Million) in 2020.
Singapore Cell And Gene Therapy Thawing Equipment Market is projected to grow at a CAGR of 23.11% during the forecast period of 2024 to 2032.
The estimated market value of the Singapore Cell And Gene Therapy Thawing Equipment Market for final year is USD 46.49 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.